🔎 Trials Near Me

홈 › 버킷 림프종 › 네바다

네바다의 버킷 림프종 임상 시험

버킷 림프종 관련 연구 6개가 네바다 내 여러 지역에서 참여자를 모집하고 있습니다.

네바다의 도시

공식 연구 텍스트(영어)

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

  • OptumCare Cancer Care at Charleston, Las Vegas
  • OptumCare Cancer Care at Fort Apache, Las Vegas
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT03739814

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

  • Alliance for Childhood Diseases/Cure 4 the Kids Foundation, Las Vegas
피험자 모집 중2상
365 Days · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06317662

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

  • OptumCare Cancer Care at Charleston, Las Vegas
  • OptumCare Cancer Care at Fort Apache, Las Vegas
피험자 모집 중3상
18세 ~ 39세 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT03150693

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

  • Alliance for Childhood Diseases/Cure 4 the Kids Foundation, Las Vegas
  • Summerlin Hospital Medical Center, Las Vegas
  • Renown Regional Medical Center, Reno
피험자 모집 중2상
1세 ~ 30세 · 모든 성별 · 2026. 9. 1. 업데이트됨 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

  • Alliance for Childhood Diseases/Cure 4 the Kids Foundation, Las Vegas
  • Summerlin Hospital Medical Center, Las Vegas
  • Renown Regional Medical Center, Reno
피험자 모집 중3상
365 Days – 25 Years · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT03959085

ClinicalTrials.gov 출처, 2026. 10. 1. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.